Depression
From the Journals
Psilocybin-Assisted Group Therapy Promising for Depression in Cancer Patients
Depression remains common in patients with cancer, and common treatment approaches have demonstrated limited success.
From the Journals
Autoimmune Diseases and Perinatal Depression May Share Two-Way Link
Study found women with autoimmune disease were 30% more likely to have perinatal depression. Risk was also 30% higher for the reverse scenario.
Latest News
Transcranial Electrical Stimulation Effective for Insomnia
tACS resulted in a statistically significant decrease in insomnia severity compared with the control group.
Latest News
African Psychedelic Tied to ‘Remarkable’ Improvement in TBI-Related Psych Symptoms, Functional Disability
The results are promising but preliminary.
Latest News
Which Therapies Reduce Daytime Symptoms of Insomnia?
Zolpidem and behavior therapy significantly reduce daytime symptoms such as fatigue, functional impairments, and...
Commentary
Cannabis for Psychiatric Disorders? ‘Not Today,’ Experts Say
Media and the state legislatures speak about cannabis as a medication for the treatment of psychiatric conditions before there is sufficient...
From the Journals
What Causes One of Stroke’s Most Common Complications?
Two studies examine a common complication following stroke, poststroke depression.
FDA/CDC
FDA Investigates Three Side Effects Reported With Weight Loss Drugs
FDA evaluating alopecia, aspiration, or suicidal ideation side effects which have been reported with weight loss medications.
Opinion
Perinatal Psychiatry in 2024: Helping More Patients Access Care
Screening and identifying women who likely suffer from postpartum depression simply is not enough.
From the Journals
Hypochondriasis Linked to Increased Risk for All-Cause Mortality
Individuals with hypochondriasis had an 84% higher risk for all-cause mortality.
From the Journals
Early evidence supports psilocybin for bipolar depression
“The results of the present study provide preliminary evidence that perhaps those with bipolar II can be safely included in study samples without...